
Daniel E. Kolker
Supervisory Patent Examiner (ID: 12246, Phone: (571)272-3181 , Office: P/1644 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1645, 1649, 1644, 1646 |
| Total Applications | 545 |
| Issued Applications | 178 |
| Pending Applications | 76 |
| Abandoned Applications | 291 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7056418
[patent_doc_number] => 20050277593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-15
[patent_title] => 'Therapeutic uses of Reg protein'
[patent_app_type] => utility
[patent_app_number] => 11/133465
[patent_app_country] => US
[patent_app_date] => 2005-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6734
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0277/20050277593.pdf
[firstpage_image] =>[orig_patent_app_number] => 11133465
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/133465 | Therapeutic uses of Reg protein | May 19, 2005 | Abandoned |
Array
(
[id] => 263780
[patent_doc_number] => 07569545
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-04
[patent_title] => 'Methods of increasing neurotrophic factor expression'
[patent_app_type] => utility
[patent_app_number] => 11/134613
[patent_app_country] => US
[patent_app_date] => 2005-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11306
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/569/07569545.pdf
[firstpage_image] =>[orig_patent_app_number] => 11134613
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/134613 | Methods of increasing neurotrophic factor expression | May 19, 2005 | Issued |
Array
(
[id] => 6978513
[patent_doc_number] => 20050288231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Biologically active peptides as glutamate receptor inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/127206
[patent_app_country] => US
[patent_app_date] => 2005-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5542
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20050288231.pdf
[firstpage_image] =>[orig_patent_app_number] => 11127206
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/127206 | Methods of inhibiting glutamate receptors by administering the tripeptide KDI | May 11, 2005 | Issued |
Array
(
[id] => 7111700
[patent_doc_number] => 20050209156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients'
[patent_app_type] => utility
[patent_app_number] => 11/119554
[patent_app_country] => US
[patent_app_date] => 2005-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 13972
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209156.pdf
[firstpage_image] =>[orig_patent_app_number] => 11119554
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/119554 | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients | May 1, 2005 | Issued |
Array
(
[id] => 5921266
[patent_doc_number] => 20060239964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Retinal degeneration'
[patent_app_type] => utility
[patent_app_number] => 11/113821
[patent_app_country] => US
[patent_app_date] => 2005-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4180
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20060239964.pdf
[firstpage_image] =>[orig_patent_app_number] => 11113821
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/113821 | Treating retinal degeneration caused by retinal vein occlusion or retinal ischemia | Apr 24, 2005 | Issued |
Array
(
[id] => 4927885
[patent_doc_number] => 20080167248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'Anti-Aging Effects Of Substance P'
[patent_app_type] => utility
[patent_app_number] => 11/587595
[patent_app_country] => US
[patent_app_date] => 2005-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2235
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20080167248.pdf
[firstpage_image] =>[orig_patent_app_number] => 11587595
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/587595 | Anti-Aging Effects Of Substance P | Apr 17, 2005 | Abandoned |
Array
(
[id] => 5865081
[patent_doc_number] => 20060099211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Safer, more potent human immunoglobulin preparations for treating Alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 11/104300
[patent_app_country] => US
[patent_app_date] => 2005-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5233
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099211.pdf
[firstpage_image] =>[orig_patent_app_number] => 11104300
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/104300 | Safer, more potent human immunoglobulin preparations for treating Alzheimer's disease | Apr 11, 2005 | Abandoned |
Array
(
[id] => 270207
[patent_doc_number] => 07563441
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-21
[patent_title] => 'Anti-P-selectin antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/102403
[patent_app_country] => US
[patent_app_date] => 2005-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 23549
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/563/07563441.pdf
[firstpage_image] =>[orig_patent_app_number] => 11102403
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/102403 | Anti-P-selectin antibodies | Apr 7, 2005 | Issued |
Array
(
[id] => 270209
[patent_doc_number] => 07563443
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-21
[patent_title] => 'Monovalent anti-CD40L antibody polypeptides and compositions thereof'
[patent_app_type] => utility
[patent_app_number] => 11/102512
[patent_app_country] => US
[patent_app_date] => 2005-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 52013
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/563/07563443.pdf
[firstpage_image] =>[orig_patent_app_number] => 11102512
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/102512 | Monovalent anti-CD40L antibody polypeptides and compositions thereof | Apr 7, 2005 | Issued |
Array
(
[id] => 252529
[patent_doc_number] => 07579161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-25
[patent_title] => 'Assay methods for suppressor of fused modulation of hedgehog signaling'
[patent_app_type] => utility
[patent_app_number] => 11/096396
[patent_app_country] => US
[patent_app_date] => 2005-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 29
[patent_no_of_words] => 34143
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/579/07579161.pdf
[firstpage_image] =>[orig_patent_app_number] => 11096396
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/096396 | Assay methods for suppressor of fused modulation of hedgehog signaling | Mar 31, 2005 | Issued |
Array
(
[id] => 6958502
[patent_doc_number] => 20050214872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Antibodies isolating and/or identifying neuronal stem cells and method for isolating and/or identifying neuronal progenitor cells'
[patent_app_type] => utility
[patent_app_number] => 11/076793
[patent_app_country] => US
[patent_app_date] => 2005-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3889
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214872.pdf
[firstpage_image] =>[orig_patent_app_number] => 11076793
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/076793 | Antibodies isolating and/or identifying neuronal stem cells and method for isolating and/or identifying neuronal progenitor cells | Mar 8, 2005 | Issued |
Array
(
[id] => 5247822
[patent_doc_number] => 20070244056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'Combination Therapy With Glatiramer Acetate and Riluzole'
[patent_app_type] => utility
[patent_app_number] => 10/591195
[patent_app_country] => US
[patent_app_date] => 2005-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14102
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20070244056.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591195
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591195 | Combination Therapy With Glatiramer Acetate and Riluzole | Mar 2, 2005 | Abandoned |
Array
(
[id] => 6958467
[patent_doc_number] => 20050214837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Antibody specific for mutant presenilin 1 and method of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/070405
[patent_app_country] => US
[patent_app_date] => 2005-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 23571
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214837.pdf
[firstpage_image] =>[orig_patent_app_number] => 11070405
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/070405 | Antibody specific for mutant presenilin 1 | Feb 23, 2005 | Issued |
Array
(
[id] => 5667585
[patent_doc_number] => 20060172935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Screening and therapeutic methods for treating circadian rhythm disorders'
[patent_app_type] => utility
[patent_app_number] => 11/048649
[patent_app_country] => US
[patent_app_date] => 2005-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 36452
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20060172935.pdf
[firstpage_image] =>[orig_patent_app_number] => 11048649
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/048649 | Screening and therapeutic methods for treating circadian rhythm disorders | Jan 30, 2005 | Abandoned |
Array
(
[id] => 7069016
[patent_doc_number] => 20050244399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Materials and method for promotion of nerve regeneration'
[patent_app_type] => utility
[patent_app_number] => 11/051996
[patent_app_country] => US
[patent_app_date] => 2005-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11656
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20050244399.pdf
[firstpage_image] =>[orig_patent_app_number] => 11051996
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/051996 | Method for promoting axonal outgrowth in damaged nerves | Jan 30, 2005 | Issued |
Array
(
[id] => 5045700
[patent_doc_number] => 20070264373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Toxin Induced Sympathectomy'
[patent_app_type] => utility
[patent_app_number] => 10/587535
[patent_app_country] => US
[patent_app_date] => 2005-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6236
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264373.pdf
[firstpage_image] =>[orig_patent_app_number] => 10587535
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/587535 | Toxin Induced Sympathectomy | Jan 25, 2005 | Abandoned |
Array
(
[id] => 7219606
[patent_doc_number] => 20050260616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Nucleotide and protein sequences of Nogo genes and methods based thereon'
[patent_app_type] => utility
[patent_app_number] => 11/044899
[patent_app_country] => US
[patent_app_date] => 2005-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 31213
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260616.pdf
[firstpage_image] =>[orig_patent_app_number] => 11044899
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/044899 | Methods of making antibodies that bind Nogo | Jan 25, 2005 | Issued |
Array
(
[id] => 5814790
[patent_doc_number] => 20060084597
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2006-04-20
[patent_title] => 'USE OF COMPOUNDS HAVING GIP ACTIVITY FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH ABNORMAL LOSS OF CELLS AND/OR FOR THE TREATMENT OF OBESITY'
[patent_app_type] => utility
[patent_app_number] => 10/518159
[patent_app_country] => US
[patent_app_date] => 2005-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14594
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A2/0084/20060084597.pdf
[firstpage_image] =>[orig_patent_app_number] => 10518159
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/518159 | USE OF COMPOUNDS HAVING GIP ACTIVITY FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH ABNORMAL LOSS OF CELLS AND/OR FOR THE TREATMENT OF OBESITY | Jan 17, 2005 | Abandoned |
Array
(
[id] => 7005079
[patent_doc_number] => 20050170392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'OAT3 transporters expressed in blood brain barrier cells'
[patent_app_type] => utility
[patent_app_number] => 11/027581
[patent_app_country] => US
[patent_app_date] => 2004-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15201
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20050170392.pdf
[firstpage_image] =>[orig_patent_app_number] => 11027581
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/027581 | OAT3 transporters expressed in blood brain barrier cells | Dec 29, 2004 | Abandoned |
Array
(
[id] => 7005080
[patent_doc_number] => 20050170393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'OATPB transporters expressed in blood brain barrier cells'
[patent_app_type] => utility
[patent_app_number] => 11/027694
[patent_app_country] => US
[patent_app_date] => 2004-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14812
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20050170393.pdf
[firstpage_image] =>[orig_patent_app_number] => 11027694
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/027694 | OATPB transporters expressed in blood brain barrier cells | Dec 29, 2004 | Abandoned |